Conflict of interest statement: The authors declare no conflict of interest.157. Mol Cell Biol. 2018 Jul 30;38(16). pii: e00298-18. doi: 10.1128/MCB.00298-18.Print 2018 Aug 15.Retraction for Wei et al., "The Breast Cancer Susceptibility Gene ProductFibroblast Growth Factor Receptor 2 Serves as a Scaffold for Regulation of NF-ÎºB Signaling".Wei W(1)(2), Liu W(1)(3), Cassol CA(1)(3), Zheng W(1), Asa SL(1)(3), EzzatS(1)(3).Author information: (1)The Ontario Cancer Institute, University Health Network, University ofToronto, Toronto, Ontario, Canada.(2)Department of Medicine, University Health Network, University of Toronto,Toronto, Ontario, Canada.(3)Department of Pathology, University Health Network, University of Toronto,Toronto, Ontario, Canada.Retraction of    Mol Cell Biol. 2012 Nov;32(22):4662-73.DOI: 10.1128/MCB.00298-18 PMID: 30061373 